Brainstorm Cell Therapeutics Inc. (BCLI) Dividend History
Income profile from 2001 to 2024 with payout safety and yield-on-cost trend
BCLI Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
BCLI Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
BCLI Dividend History
No dividend payment history available
Dividend Analysis
Payout Safety
Brainstorm Cell Therapeutics Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
BCLI does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, BCLI returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -98.6%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $210 today.
BCLI Annual Dividend History (2001–2024)
23 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | — | 0 | $2.19 | — | — | — |
| 2023 | $0.00 | — | 0 | $-4.48 | — | — | — |
| 2022 | $0.00 | — | 0 | $-9.93 | — | — | — |
| 2021 | $0.00 | — | 0 | $-10.09 | — | — | — |
| 2020 | $0.00 | — | 0 | $-14.09 | — | — | — |
| 2019 | $0.00 | — | 0 | $-13.64 | — | — | — |
| 2018 | $0.00 | — | 0 | $-10.05 | — | — | — |
| 2017 | $0.00 | — | 0 | $-3.92 | — | — | — |
| 2016 | $0.00 | — | 0 | $-4.00 | — | — | — |
| 2015 | $0.00 | — | 0 | $-6.88 | — | — | — |
See BCLI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCLI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCLI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCLI — Frequently Asked Questions
Quick answers to the most common questions about buying BCLI stock.
How much dividend does BCLI pay per share?
Brainstorm Cell Therapeutics Inc. (BCLI) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is BCLI's next ex-dividend date?
BCLI's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. BCLI typically pays dividends quarterly.
Is BCLI's dividend safe?
BCLI's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has BCLI increased its dividend?
BCLI has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does BCLI pay dividends?
Brainstorm Cell Therapeutics Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 23+ years from 2001 to 2024.
How much would $10,000 invested in BCLI grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in BCLI five years ago would be worth approximately $144 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is BCLI's yield on cost for long-term holders?
BCLI's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.